An mRNA biotech company developing self-improving drug platforms for cancer, infectious disease, and other conditions.
HelixNano is building a next-generation mRNA platform aimed at making drug development faster, cheaper, and more decentralized. The website presents an aspirational vision of self-designing drugs that improve with every patient treated, but no specific commercial product details, clinical programs, or pricing are publicly disclosed on the site at this time. HelixNano is a product of Helix Nanotechnologies.